The German regulatory authority has given approval to Dr Reddy’s, Visakhapatnam based plant to restart production for the European market (EU).

In a regulatory filing the company stated, “The corrective and preventive action plan (CAPA) submitted by us has been accepted by the regulator. Consequently, the regulator has permitted production to start again from this facility for the EU market.”

Further, it added that there will be a re-inspection of the facility by the end of 2018. Moreover, no details were given by the company on the observations which were made by the regulator related to violations of good manufacturing practices (GMP).

Read EquityPandit’s Technical Analysis of Dr Reddy Outlook for the Week